
1. j med virol. 1990 jul;31(3):200-8.

association antibodies blocking hiv-1 gp 160-scd4 attachment virus
neutralizing activity human sera.

back nk(1), thiriart c, delers a, ramautarsing c, bruck c, goudsmit j.

author information: 
(1)department virology, academic medical centre, amsterdam, netherlands.

sera, hiv-1 hiv-2 seropositive individuals, tested presence
of antibodies able inhibit binding (bi) hiv-iiib gp 160 (produced in
mammalian cells using vaccinia expression system) extracellular portion 
of cd4 receptor. competition enzyme immunoassay (eia) soluble cd4
(scd4) used. bi antibodies highly prevalent among hiv-1 seropositives
but hiv-2 infected individuals. attempts localize binding site 
these bi antibodies primary sequence gp 120 using synthetic peptides
encompassing putative cd4 binding site gp 120 (aa 397-439) not
successful. study reveal significant correlation the
presence bi antibodies disease evolution. bi antibody titres correlated
less well anti-gp 160 titres (r = 0.51, p less equal 0.011) 
with neutralizing antibody (na) titres using either isolates hiv-sf2 (sf2) (r
= 0.77, p less equal 0.000) hiv-mn (mn) (r = 0.61, p less 
equal 0.002) isolate hiv-iiib (hx10) (r = 0.89, p less equal to
0.000) gp 160 assays derived. hiv-iiib neutralizing
serum, elicited rabbit immunization 17-mer synthetic peptide
derived third variable domain (v3) gp 120, bind gp 160 without
inhibiting subsequent attachment scd4 gp 160.(abstract truncated 250
words)

doi: 10.1002/jmv.1890310306 
pmid: 1697332  [indexed medline]

